· Vision and Mission
Qizheng Tibetan Medicine Leads the Development of Tibetan Medicine in China
Release time:
2012-12-21 14:53
Qizheng Tibetan Medicine Leads the Development of Tibetan Medicine in China
— The event organizing committee visits Qizheng Tibetan Medicine.
Recently, a delegation from the event organizing committee visited Qizheng Tibetan Medicine to conduct on-site research, interviews, and filming. Mr. Liu Kailie, Director and General Manager of the company, was invited to give an interview.
Tibet Qizheng Tibetan Medicine Co., Ltd. is the largest Tibetan medicine manufacturer in China, primarily engaged in the research and development, production, and sales of innovative Tibetan medicines. Currently, the company has 15 wholly-owned and controlling subsidiaries, including GMP-certified pharmaceutical factories and GSP-compliant marketing companies. It holds 69 patented technologies and possesses 73 drug approval numbers, among which 12 are listed in the National Medical Insurance Catalogue, 12 are exclusive products, 1 is a protected traditional Chinese medicine product, and 2 are classified as state-confidential. Its product portfolio covers areas such as cardiovascular and cerebrovascular diseases, respiratory system disorders, digestive system ailments, urogenital system conditions, nervous system disorders, musculoskeletal system diseases, and gynecological disorders. The company has successively received numerous prestigious awards, including being named among the first batch of National Innovative Enterprises, a Key High-Tech Enterprise under the National Torch Program, a National Enterprise Technology Center, an implementation unit for key projects under the National “11th Five-Year” Science and Technology Support Plan, one of the Top 100 National Brand Enterprises, among the Top 50 Most Competitive Listed Pharmaceutical Companies in China, among the Top 20 Core Competitiveness Enterprises in the Traditional Chinese Medicine Sector, one of the Top 10 Growing Brands in the Traditional Chinese Medicine Industry, and among the Top 100 Brands in China’s Traditional Chinese Medicine Industry.
Over the past two decades of development, the company has, through the practice of its core values—“doing good and benefiting others, pursuing integrity and excellence in business”—explored an operational system characterized by “ethnic integration, cultural fusion, technological convergence, and talent integration.” Upholding its mission of “promoting health wisdom and returning to inner and outer freedom,” the company has established a harmonious management model for ethnic pharmaceutical enterprises, pioneered a path for innovative development in the Tibetan medicine industry, and successfully developed a model for transforming millennia-old Tibetan medicinal practices into the modern market. As a result, the company has forged its own distinctive core strengths: outstanding brand building, leading-edge channel marketing, robust R&D innovation ensuring a steady pipeline of new products, abundant resources in Tibetan regions, comprehensive modern pharmaceutical research, a strong financial position, and a profound cultural heritage.
How has Qizheng Tibetan Medicine, once an obscure private enterprise, steadily grown to become a leader in the Tibetan medicine industry? Mr. Liu Kailie emphasized that inheriting the health wisdom of traditional ethnic medicine is something that ethnic pharmaceutical companies must steadfastly uphold. Yet, in this process, innovation is even more crucial—only through innovation can enterprises thrive and truly carry forward the essence of ethnic medicine. “Today’s continuous innovation is precisely for better preserving our heritage in the future.”
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO